EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Vascularized liver-on-a-chip model to investigate nicotine-induced dysfunction

Eric Wang iD, Melisa J Andrade iD, Quinton Smith iD

Biomicrofluidics · 01.12.2023 · 17 (6)

DOI: 10.1063/5.0172677 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomicrofluidics, online erschienen am 27.12.2023. Verfasst von Eric Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, University of California Irvine, Irvine, California 92697, USA. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Howard Hughes Medical Institute, National Institutes of Health.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of physiologically relevant in vitro systems for simulating disease onset and progression and predicting drug metabolism holds tremendous value in reducing drug discovery time and cost. However, many of these platforms lack accuracy in replicating the tissue architecture and multicellular interactions. By leveraging three-dimensional cell culture, biomimetic soft hydrogels, and engineered stimuli, in vitro models have continued to progress. Nonetheless, the incorporation of the microvasculature has been met with many challenges, specifically with the addition of parenchymal cell types. Here, a systematic approach to investigating the initial seeding density of endothelial cells and its effects on interconnected networks was taken and combined with hepatic spheroids to form a liver-on-a-chip model. Leveraging this system, nicotine's effects on microvasculature and hepatic function were investigated. The findings indicated that nicotine led to interrupted adherens junctions, decreased guanosine triphosphate cyclohydrolase 1 expression, impaired angiogenesis, and lowered barrier function, all key factors in endothelial dysfunction. With the combination of the optimized microvascular networks, a vascularized liver-on-a-chip was formed, providing functional xenobiotic metabolism and synthesis of both albumin and urea. This system provides insight into potential hepatotoxicity caused by various drugs and allows for assessing vascular dysfunction in a high throughput manner.

Autor:innen und Institutionen

  • Department of Chemical and Biomolecular Engineering, University of California Irvine, Irvine, California 92697, USA.

ORCID-Profile: Eric Wang, Melisa J Andrade, Quinton Smith

Förderung

  • NIGMS NIH HHS
  • Howard Hughes Medical Institute
  • National Institutes of Health

Zitieren

APA

Wang, E., Andrade, M. J., & Smith, Q. (2023). Vascularized liver-on-a-chip model to investigate nicotine-induced dysfunction. Biomicrofluidics, 17(6). https://doi.org/10.1063/5.0172677

Vancouver

Wang E, Andrade MJ, Smith Q. Vascularized liver-on-a-chip model to investigate nicotine-induced dysfunction. Biomicrofluidics. 2023;17(6). doi:10.1063/5.0172677

BibTeX
@article{Wang2023,
  author = {Wang, Eric and Andrade, Melisa J and Smith, Quinton},
  title = {Vascularized liver-on-a-chip model to investigate nicotine-induced dysfunction},
  journal = {Biomicrofluidics},
  year = {2023},
  volume = {17},
  number = {6},
  doi = {10.1063/5.0172677}
}
Kostenlos starten →